Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 25, 2024Open Access

Validation of the Molecular International Prognostic Scoring System (IPSS-M) for myelodysplastic neoplasms (MDS) and comparison with the revised International Prognostic Scoring System (IPSS-R) in Chinese Population: A Multicenter Retrospective Study.

View Full Paper
Ask AI
Bookmark
Share

Authors

MHMengmeng HuChongqing Technology and Business UniversityMZMing ZhouZhejiang Chinese Medical UniversityYSYingying ShenGuangdong University Of Finances and Economics

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Hu et al. (2024) studied this question.

synapsesocial.com/papers/68e72763b6db6435876a104bhttps://doi.org/10.21203/rs.3.rs-4129078/v1
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1IPSS-m outperforms IPSS-R in younger adults with Myelodysplastic Syndromes: A retrospective age-stratified analysis2025
  2. 2IPSS, IPSS-R and IPSS-M had no identical prognostic power depending on treatment in myelodysplastic syndromes2026
  3. 3Validation of the Artificial Intelligence Prognostic Scoring System for Myelodysplastic Syndromes in chronic myelomonocytic leukaemia: A novel approach for improved risk stratification2024 · 7 citations
  4. 4Assessing the Relevance of Non-molecular Prognostic Systems for Myelodysplastic Syndrome in the Era of Next-Generation Sequencing2024 · 3 citations
  5. 5Comparison of the prognostic predictive value of Molecular International Prognostic Scoring System and Revised International Prognostic Scoring System in patients undergoing allogeneic hematopoietic stem cell transplantation for myelodysplastic neoplasms2023 · 5 citations